LGG-29. Use of Bevacizumab in Pediatric Low-grade Glioma: Ten-year experience in a single center

PURPOSE: Pediatric low-grade gliomas (PLGG) have excellent overall survival but frequently need non-surgical therapy at diagnosis or after progression at unresectable sites such as the optic pathway. Chemotherapy side effects have led to the need for better-tolerated regimens with a sustained respon...

Descripción completa

Detalles Bibliográficos
Autores principales: Rafael, Margarida Simão, Cruz, Ofelia, Perez-Jaume, Sara, Santa-María, Vicente, Lavarino, Cinzia, Salvador, Hector, Muchart, Jordi, Hinojosa, Jose, Suñol, Mariona, Morales, Andrés
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Low Grade Glioma
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164899/
http://dx.doi.org/10.1093/neuonc/noac079.342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164899/
http://dx.doi.org/10.1093/neuonc/noac079.342

Ejemplares similares